Recherchiere Firmenbekanntmachungen und finanzielle Kennzahlen
EU-Förderung (173.076 €): Die Rolle von CD63 beim lysosomalen Abbau von Insulingranulat in Betazellen der Bauchspeicheldrüse bei T2D-Diabetes Hor29.05.2018 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Die Rolle von CD63 beim lysosomalen Abbau von Insulingranulat in Betazellen der Bauchspeicheldrüse bei T2D-Diabetes
The pancreatic β cell harbors an exemplary nutrient sensing machinery that is coupled to secretion of insulin. While mechanisms governing regulation of insulin secretion in response to nutrients were widely investigated, little is known about how nutrients impact on other basic cellular processes such as insulin granule turnover, autophagy and cellular growth, deregulation of all of which have been demonstrated to be involved in β cell failure in type 2 diabetes (T2D). T2D represents a major health burden accounting for a large part of exploding health costs world-wide. Restoring normal weight through exercise and decreased food consumption in principle is straight-forward to mitigate metabolic disturbances. However, changing the sedentary life style is very challenging for obese subjects and that at a late disease stage, β cell failure becomes irreversible. There is an emerging endeavor of the pharmaceutical industry to develop strategies targeting the β cell that go beyond improving insulin secretion. A prevailing concept in cell biology is that enhanced degradation of cellular components through autophagy can counteract energy depletion caused by shortage of environmental nutrients. My host laboratory recently discovered that β cells employ a very distinct and so far unknown mechanism to adapt to nutrient depletion. β cells induce specific degradation of newly formed insulin granules through lysosomes and suppress autophagy upon nutrient withdrawal. Insulin granule degradation allows for generation of intracellular nutrients and in the same time avoids release of these granules. Their preliminary results suggest that lysosomal insulin granule degradation is dramatically enhanced in β cells of diabetic islets from mice and humans. This increase is accompanied by a drop in autophagy, a known protective process in the β cell. My project will fortify that impaired lysosomal activity, insulin degradation and suppressed autophagy contribute to β cell failure in T2D.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Centre Europeen de Recherche en Biologie et Medecine | 173.076 € |
Quelle: https://cordis.europa.eu/project/id/798961
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der aktuelle Stand wird auf folgender Seite wiedergegeben: Centre Europeen de Recherche en Biologie et en Medecine GIE, Illkirch-Graffenstaden, Frankreich.
Die Visualisierungen zu "Centre Europeen de Recherche en Biologie et Medecine - EU-Förderung (173.076 €): Die Rolle von CD63 beim lysosomalen Abbau von Insulingranulat in Betazellen der Bauchspeicheldrüse bei T2D-Diabetes"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
